Archives of cardiovascular diseases
-
Arch Cardiovasc Dis · Aug 2015
ReviewA critical appraisal of the guidelines from France, the UK, Europe and the USA for the management of hypertension in adults.
Hypertension is the leading cause of death in developed countries; its management is the subject of guidelines that are regularly reviewed and updated. However, the guidelines from France, the UK, Europe and the USA differ. Some recommendations are graded, whereas others are not. ⋯ In the French and European guidelines, diuretics, beta-blockers, calcium antagonists, angiotensin-converting enzyme (ACE) inhibitors and angiotensin II type 1 receptor blockers (ARBs) remain indicated as first-line therapy for hypertension; if the target blood pressure is not achieved, they recommend combining two active substances. The UK guideline recommends ACE inhibitors or ARBs as first-line therapy for patients aged <55 years; calcium antagonists are advised for patients aged >55 years and for black patients. The USA guideline advises treating non-black patients, including those with diabetes, with thiazides, calcium antagonists, ACE inhibitors or ARBs; for black patients, including those with diabetes, it recommends thiazide and calcium antagonists.
-
Arch Cardiovasc Dis · Nov 2014
ReviewTranscatheter pulmonary valvulation: current indications and available devices.
Since the first transcatheter implantation of a pulmonary valve in 2000 in a twelve year-old boy with a dysfunctional right ventricle to pulmonary artery conduit by Philip Bonhoeffer and Younes Boudjemline, the Melody(®) valve has become worldwide used. It represents an efficient alternative to open-heart surgery. We aimed in this comprehensive review to describe the current indications of percutaneous pulmonary valve implantation, the devices currently used and the clinical results.
-
Arch Cardiovasc Dis · Nov 2014
ReviewPercutaneous pulmonary valve endocarditis: incidence, prevention and management.
The epidemiology of infective endocarditis is changing rapidly due to the emergence of resistant microorganisms, the indiscriminate use of antibiotics, and an increase in the implantation of cardiovascular devices including percutaneous valves. Percutaneous pulmonary valve implantation has achieved standard of care for the management of certain patients with right ventricular outflow tract dysfunction. With its expanding use, several cases of early and delayed infective endocarditis with higher morbidity and mortality rates have been reported. This review summarizes the trends in percutaneous pulmonary valve infective endocarditis, postulates proposed mechanisms, and elaborates on the prevention and management of this unique and potentially fatal complication.
-
Arch Cardiovasc Dis · Oct 2014
ReviewLeft ventricular performance is closely related to the physical properties of the arterial system: Landmark clinical investigations in the 1970s and 1980s.
Left ejection fraction (LVEF)--resulting from the difference between end-diastolic volume (EDV) and end-systolic volume (ESV), divided by EDV--is a poor index of left ventricular (LV) systolic performance due to its dependency on load conditions, inotropic state and LV remodelling. The characteristic impedance of the ascending aorta (Zc) integrates factors opposing LV ejection during the early ejection period when arterial wave reflection can be neglected. Zc is related to the pressure wave velocity (C) and the cross-sectional area of the aorta. ⋯ Increased arterial stiffness resulted in increasing C and overlap of forward and backward waves and thereby in greater pulse pressure and ESP and a greater difference between ESP and diastolic pressure. Ees is an accurate index of LV systolic performance. Besides the inotropic state of myofibers, Ees depends on the concentric remodelling and thereby on the characteristic impedance of the aorta.
-
Arch Cardiovasc Dis · Jun 2014
ReviewMechanical circulatory support for infants and small children.
The number of children in need of mechanical circulatory support has increased substantially over the last two decades, due to the technological progress made in surgery and intensive care, leading to improved survival of patients with congenital heart disease. In addition, primary myocardial dysfunction related to myocarditis or dilated cardiomyopathy may cause end-stage cardiac failure in children or infants, although not as frequently as in adults. ⋯ Two types of mechanical circulatory devices are suitable for the paediatric population: extracorporeal membrane oxygenation for short-term support; and ventricular assist devices for long-term support as a bridge to transplantation. The aim of this review is to describe the specific issues related to paediatric mechanical circulatory support and the different types of devices available, to report on their rapidly growing use worldwide and on the outcomes for each indication and type of device, and to provide a perspective on the future developments and remaining challenges in this field.